Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2025 年第 2 季持倉
持倉截至 2025/6/30，2025/8/14 申報。只含多頭部位，變化是跟 2025 年第 1 季比股數。
- 持股檔數
- 82
- 較 2025 年第 1 季 −4
- 總值
- $26.7 億
- 較 2025 年第 1 季 −$1.55 億 (−5.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| VRNAVerona Pharma plc | SPONSORED ADS | 5,507,591 | $5.21 億 | 19.5% | −1,055,749−16.1% | 減碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 963,886 | $1.66 億 | 6.2% | +963,886 | 新進 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 2,478,000 | $1.63 億 | 6.1% | −448,478−15.3% | 減碼 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 2,418,299 | $1.53 億 | 5.7% | −130,146−5.1% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,375,180 | $1.05 億 | 3.9% | −258,788−15.8% | 減碼 | 歷史 |
| AORTArtivion, Inc. | COM | 2,793,703 | $8,688 萬 | 3.3% | 00.0% | 不變 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 12,626,103 | $8,223 萬 | 3.1% | +45,000+0.4% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 650,252 | $6,544 萬 | 2.5% | +140,952+27.7% | 加碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 4,639,949 | $6,083 萬 | 2.3% | −1,907,379−29.1% | 減碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,074,448 | $5,938 萬 | 2.2% | −16,823−1.5% | 減碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 11,906,646 | $5,799 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,182,148 | $5,134 萬 | 1.9% | +59,381+5.3% | 加碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 7,902,365 | $5,065 萬 | 1.9% | +28,017+0.4% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 9,383,456 | $5,048 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 915,887 | $4,887 萬 | 1.8% | +122,927+15.5% | 加碼 | 歷史 |
| OMDAOmada Health, Inc. | COM | 2,426,330 | $4,440 萬 | 1.7% | +2,426,330 | 新進 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 7,412,830 | $4,248 萬 | 1.6% | −14,051,697−65.5% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 3,331,465 | $3,755 萬 | 1.4% | +3,331,465 | 新進 | 歷史 |
| MRUSMerus N.V. | COM | 708,176 | $3,725 萬 | 1.4% | +17,691+2.6% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 430,439 | $3,606 萬 | 1.4% | −1,076,163−71.4% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 6,485,420 | $3,476 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| IMVTImmunovant, Inc. | COM | 2,137,890 | $3,421 萬 | 1.3% | −706,182−24.8% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 255,050 | $3,206 萬 | 1.2% | +155,000+154.9% | 加碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 752,921 | $3,166 萬 | 1.2% | −227,973−23.2% | 減碼 | 歷史 |
| BSXBoston Scientific Corp | Stock | 280,000 | $3,007 萬 | 1.1% | +150,000+115.4% | 加碼 | 歷史 |
| CAICaris Life Sciences, Inc. | COM | 1,098,163 | $2,934 萬 | 1.1% | +1,098,163 | 新進 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 45,119 | $2,452 萬 | 0.9% | +4,500+11.1% | 加碼 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 1,303,468 | $2,374 萬 | 0.9% | −69,765−5.1% | 減碼 | 歷史 |
| BBNXBeta Bionics, Inc. | COM | 1,593,608 | $2,320 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,529,445 | $2,290 萬 | 0.9% | −783,827−33.9% | 減碼 | 歷史 |
| EOLSEvolus, Inc. | COM | 2,474,843 | $2,279 萬 | 0.9% | −1,654,299−40.1% | 減碼 | 歷史 |
| CELCCelcuity Inc. | COM | 1,633,208 | $2,180 萬 | 0.8% | −729,071−30.9% | 減碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,247,390 | $2,140 萬 | 0.8% | −66,013−2.9% | 減碼 | 歷史 |
| SIONSionna Therapeutics, Inc. | COM | 1,216,045 | $2,110 萬 | 0.8% | −35,056−2.8% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 198,534 | $2,072 萬 | 0.8% | −156,573−44.1% | 減碼 | 歷史 |
| RGENRepligen Corp | COM | 166,000 | $2,065 萬 | 0.8% | +36,199+27.9% | 加碼 | 歷史 |
| PODDInsulet Corp | Stock | 60,387 | $1,897 萬 | 0.7% | −11,210−15.7% | 減碼 | 歷史 |
| OMOutset Medical, Inc. | COM NEW | 833,333 | $1,601 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 1,275,274 | $1,600 萬 | 0.6% | −589,398−31.6% | 減碼 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 6,993,646 | $1,588 萬 | 0.6% | +6,993,646 | 新進 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 4,051,631 | $1,552 萬 | 0.6% | −5,224,220−56.3% | 減碼 | 歷史 |
| CRLCharles River Laboratories International, Inc. | COM | 100,000 | $1,517 萬 | 0.6% | +100,000 | 新進 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,146,935 | $1,507 萬 | 0.6% | −1,893,460−62.3% | 減碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 977,892 | $1,395 萬 | 0.5% | −86,134−8.1% | 減碼 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 9,876,576 | $1,284 萬 | 0.5% | +64,157+0.7% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 1,096,985 | $1,249 萬 | 0.5% | +799,432+268.7% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 834,252 | $1,235 萬 | 0.5% | +834,252 | 新進 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 4,592,556 | $1,231 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| DRUGBright Minds Biosciences Inc. | COM NEW | 420,690 | $1,098 萬 | 0.4% | −23,959−5.4% | 減碼 | 歷史 |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 5,432,293 | $1,059 萬 | 0.4% | −492,707−8.3% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 380,700 | $1,009 萬 | 0.4% | −128,305−25.2% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 270,000 | $981.7 萬 | 0.4% | +270,000 | 新進 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 210,106 | $916.9 萬 | 0.3% | +210,106 | 新進 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 12,594,211 | $913.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| PENPenumbra Inc | COM | 32,797 | $841.7 萬 | 0.3% | +32,797 | 新進 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 453,686 | $732.2 萬 | 0.3% | +453,686 | 新進 | 歷史 |
| AQSTAquestive Therapeutics, Inc. | COM | 2,190,420 | $725.0 萬 | 0.3% | −1,536,788−41.2% | 減碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 292,686 | $676.1 萬 | 0.3% | −677,726−69.8% | 減碼 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 1,705,130 | $646.2 萬 | 0.2% | −434,870−20.3% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 200,791 | $628.5 萬 | 0.2% | −124,533−38.3% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 447,507 | $625.6 萬 | 0.2% | −212,155−32.2% | 減碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,438,595 | $575.4 萬 | 0.2% | +1,438,595 | 新進 | 歷史 |
| SEPNSepterna, Inc. | COM | 541,450 | $572.3 萬 | 0.2% | +541,450 | 新進 | 歷史 |
| GMEDGlobus Medical Inc | Stock | 88,500 | $522.3 萬 | 0.2% | +88,500 | 新進 | 歷史 |
| NVNOenVVeno Medical Corp | COMMON STOCK | 1,284,966 | $512.7 萬 | 0.2% | +1,284,966 | 新進 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 398,000 | $422.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IRDOpus Genetics, Inc. | COM | 4,325,000 | $407.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CTNMContineum Therapeutics, Inc. | CL A | 699,486 | $277.7 萬 | 0.1% | −741,763−51.5% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM NEW | 255,150 | $228.6 萬 | 0.1% | 00.0% | 不變依 1 比 50 拆股換算 | 歷史 |
| SCPHscPharmaceuticals Inc. | COM | 500,000 | $190.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LONALeonaBio, Inc. | COM | 5,402,964 | $163.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 183,890 | $147.1 萬 | 0.1% | +183,890 | 新進 | 歷史 |
| TRIBTrinity Biotech PLC | SPONS ADR NEW | 1,790,000 | $116.3 萬 | <0.1% | +1,790,000 | 新進 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 68,192 | $88.2 萬 | <0.1% | +68,192 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 139,667 | $69.7 萬 | <0.1% | −380,333−73.1% | 減碼 | 歷史 |
| BDSXBiodesix Inc | COM | 2,173,880 | $61.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 139,835 | $56.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| APYXApyx Medical Corp | COM | 150,000 | $33.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| KALAKALA BIO, Inc. | COMM STK | 55,227 | $26.3 萬 | <0.1% | −222,383−80.1% | 減碼 | 歷史 |
| ENSCEnsysce Biosciences, Inc. | COM NEW | 86,666 | $19.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RVMDWRevolution Medicines, Inc. | *W EXP 12/17/202 | 250,000 | $6.57 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 166,666 | $3,017 | <0.1% | 00.0% | 不變 | – |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $2,488 萬 | – |
| CAPRCapricor Therapeutics, Inc. | COM NEW | $645.5 萬 | $99.3 萬 |
2025 年第 1 季之後清倉（22 檔）
2025 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 1 季股數 | 2025 年第 1 季市值 | 2025 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ITCIIntra-Cellular Therapies, Inc. | COM | 786,358 | $1.04 億 | 3.7% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 12,711,788 | $4,233 萬 | 1.5% | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 59,510 | $3,522 萬 | 1.2% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 706,567 | $2,668 萬 | 0.9% | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 46,500 | $1,540 萬 | 0.5% | 歷史 |
| DXCMDexcom Inc | COM | 178,000 | $1,216 萬 | 0.4% | 歷史 |
| ACRVAcrivon Therapeutics, Inc. | COMMON STOCK | 5,360,858 | $1,088 萬 | 0.4% | 歷史 |
| CRGXCARGO Therapeutics, Inc. | COM | 2,431,085 | $989.5 萬 | 0.4% | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 1,537,274 | $833.2 萬 | 0.3% | 歷史 |
| IRONDisc Medicine, Inc. | COM | 150,000 | $744.6 萬 | 0.3% | 歷史 |
| ADPTAdaptive Biotechnologies Corp | COM | 930,972 | $691.7 萬 | 0.2% | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 915,775 | $671.3 萬 | 0.2% | 歷史 |
| DCTHDelcath Systems, Inc. | COM NEW | 462,422 | $588.7 萬 | 0.2% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 4,418,947 | $539.1 萬 | 0.2% | 歷史 |
| KMTSKestra Medical Technologies, Ltd. | SHS | 200,000 | $498.4 萬 | 0.2% | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 1,004,439 | $431.9 萬 | 0.2% | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 876,961 | $197.3 萬 | 0.1% | 歷史 |
| TRAWTraws Pharma, Inc. | COM NEW | 421,781 | $97.0 萬 | <0.1% | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 140,726 | $93.9 萬 | <0.1% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 80,100 | $60.6 萬 | <0.1% | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 860,000 | $42.0 萬 | <0.1% | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 105,053 | $37.6 萬 | <0.1% | 歷史 |